Chromadex Corp
NASDAQ:CDXC
Operating Margin
Chromadex Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Chromadex Corp
NASDAQ:CDXC
|
598.5m USD |
8%
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
15%
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
176.2B USD |
18%
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
141.6B USD |
20%
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW |
32%
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
40.5B CHF |
18%
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.9B USD |
23%
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
242.8B CNY |
27%
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
33.8B USD |
15%
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.1B USD |
29%
|
|
| IN |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1.8T INR |
28%
|
Chromadex Corp
Glance View
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Chromadex Corp's most recent financial statements, the company has Operating Margin of 7.8%.
You don't have any saved screeners yet